Nucleic acid-controlled catalytic rnas for trigger-responsive regulation
US-2024425855-A1 · Dec 26, 2024 · US
US9487779B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9487779-B2 |
| Application number | US-201414297378-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2014 |
| Priority date | Aug 5, 2002 |
| Publication date | Nov 8, 2016 |
| Grant date | Nov 8, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to small interfering RNA molecules (siRNA) targeted against an allele of interest, and methods of using these siRNA molecules.
Opening claim text (preview).
What is claimed is: 1. A mammalian cell comprising a first strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein the first strand is complementary to at least 15 nucleotides of a mutant Ataxin-3 transcript encoded by siC7 (5′-CTGTCCTGATAGGTCCCGCTGC-3′ SEQ ID NO: 16), siG10 (5′-CTGATAGGTCCCCCTGCTGC-3′ SEQ ID NO:18), siC7/8 (5′-CTGTCCTGATAGGTCCGGCTGC-3′ SEQ ID NO:20), or siC10 (5′-CTGATAGGTCCCGCTGCTGC-3′ SEQ ID NO:22), and wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and a second strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein at least 12 nucleotides of the first and second strands are complementary to each other and form a small interfering RNA (siRNA) duplex under physiological conditions, and wherein the siRNA silences only one allele of the targeted gene in the cell. 2. The cell of claim 1 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure. 3. The cell of claim 2 , wherein the loop structure contains from 4 to 10 nucleotides. 4. An isolated RNA duplex comprising a first strand of RNA having a 5′ end and a 3′ end, and a second strand of RNA, wherein the first strand comprises 22 nucleotides complementary to mutant Ataxin-3 transcript encoded by siC7 (5′-CTGTCCTGATAGGTCCCGCTGC-3′ SEQ ID NO: 16), siG10 (5′-CTGATAGGTCCCCCTGCTGC-3′ SEQ ID NO:18), siC7/8 (5′-CTGTCCTGATAGGTCCGGCTGC-3′ SEQ ID NO:20), or siC10 (5′-CTGATAGGTCCCGCTGCTGC-3′ SEQ ID NO:22), wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and wherein the second strand is complementary to all the nucleotides of the first strand. 5. The RNA duplex of claim 4 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure. 6. The RNA duplex of claim 4 , wherein the loop structure contains from 4 to 10 nucleotides. 7. An expression cassette comprising a nucleic acid encoding at least one strand of the RNA duplex of claim 4 . 8. A vector comprising the expression cassette of claim 7 . 9. A vector comprising two expression cassettes, a first expression cassette comprising a nucleic acid encoding the first strand of the RNA duplex of claim 4 and a second expression cassette comprising a nucleic acid encoding the second strand of the RNA duplex of claim 4 . 10. A cell comprising the expression cassette of claim 7 . 11. An isolated RNA duplex comprising a first strand of RNA having a 5′ end and a 3′ end, and a second strand of RNA, wherein the first strand comprises 22 nucleotides complementary to mutant APP transcript encoded by siT8/C9 (5′-ATTCTGCATCCAGATTCACT-3′ SEQ ID NO: 83), siT9/C10 (5′-TTCTGCATCCAGATTCACTT-3′ SEQ ID NO:85), siT10/C11 (5′-TCTGCATCCAGATTCACTTC-3′ SEQ ID NO:86), siT11/C12 (5′-TGCATCCAGATTCACTTCA-3′ SEQ ID NO:88), or siT12/C13 (5′-TGCATCCAGATTCACTTCAG-3′ SEQ ID NO: 90), wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and wherein the second strand is complementary to all the nucleotides of the first strand. 12. The RNA duplex of claim 11 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure. 13. The RNA duplex of claim 11 , wherein the loop structure contains from 4 to 10 nucleotides. 14. An expression cassette comprising a nucleic acid encoding at least one strand of the RNA duplex of claim 11 . 15. A vector comprising the expression cassette of claim 14 . 16. A vector comprising two expression cassettes, a first expression cassette comprising a nucleic acid encoding the first strand of the RNA duplex of claim 14 and a second expression cassette comprising a nucleic acid encoding the second strand of the RNA duplex of claim 14 . 17. A cell comprising the expression cassette of claim 14 . 18. A mammalian cell comprising an isolated first strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein the first strand is complementary to at least 15 nucleotides of mutant APP transcript encoded by siT8/C9 (5′-ATTCTGCATCCAGATTCACT-3′ SEQ ID NO: 83), siT9/C10 (5′-TTCTGCATCCAGATTCACTT-3′ SEQ ID NO:85), siT10/C11 (5′-TCTGCATCCAGATTCACTTC-3′ SEQ ID NO:86), siT11/C12 (5′-TGCATCCAGATTCACTTCA-3′ SEQ ID NO:88), or siT12/C13 (5′-TGCATCCAGATTCACTTCAG-3′ SEQ ID NO: 90), and wherein the 5′ end of the first strand of RNA is operably linked to a G nucleotide to form a first segment of RNA, and an isolated second strand of RNA of 15 to 30 nucleotides in length having a 5′ end and a 3′ end, wherein at least 12 nucleotides of the first and second strands are complementary to each other and form a small interfering RNA (siRNA) duplex under physiological conditions, and wherein the siRNA silences only one allele of the targeted gene in the cell. 19. The cell of claim 18 , wherein the first strand and the second strand are operably linked by means of an RNA loop strand to form a hairpin structure comprising a duplex structure and a loop structure. 20. The cell of claim 19 , wherein the loop structure contains from 4 to 10 nucleotides.
Beta-glucuronidase (3.2.1.31) · CPC title
Animals comprising random inserted nucleic acids (transgenic) · CPC title
for the expression of a heterologous nucleic acid · CPC title
spanning the whole gene, or a large part of it · CPC title
against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.